VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) is a prescription medicine used with or without ribavirin to treat adults with genotype 1 chronic hepatitis C (hep C) virus infection, including people who have a certain type of cirrhosis (compensated).Read More >>
The recommended oral dosage of VIEKIRA PAK is two ombitasvir, paritaprevir, ritonavir tablets once daily (in the morning) and one dasabuvir tablet twice daily (morning and evening). Download our Hepatitis C Reference Chart for information on all of these variables, including dosage recommendations for the other HCV medications that Avella provides.Read More >>
Do not use VIEKIRA PAK for a condition for which it was not prescribed. Do not give VIEKIRA PAK to other people, even if they have the same symptoms you have. If you would like more information about VIEKIRA PAK, talk with your provider or ask our pharmacists.Read More >>
This exclusive downloadable reference chart provides a resource for prescribing the latest hepatitis C medications including Viekira. This chart includes reference information for prescribers such as:
The Latest Hepatitis C Medication Information & Patient Resources from Avella Specialty Pharmacy.
Subscribe to email updates including HCV news, innovations and breakthroughs, policy updates & public health info.
Access the latest and most up-to-date hepatitis C treatment resource information for your patients and their families.
I just wanted to take the time to tell you how wonderful the staff at Avella is! They are always so quick to respond and so helpful. They are all knowledgeable and always able to get us the information we need.
We recently had a patient that was denied hepatitis C treatment and they were quick to start the appeal process and get us an appeal letter that only needed to be signed by the physician. We all really appreciate all that Avella does!